<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), considered a pre-leukemic state, has recently been categorized as a subset of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes </plain></SENT>
<SENT sid="1" pm="."><plain>Unlike other subtypes of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes, such as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> or <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita, little is known about genetic alterations of human telomerase in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, despite the fact that immune cells from patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> frequently exhibit telomere attrition </plain></SENT>
</text></document>